Global Erectile Dysfunction Market Market Size
The market for erectile dysfunction was valued at US$5.54 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 6.2% to reach US$10.14 billion by 2030.
Impotence is another term for erectile dysfunction. When men are unable to maintain an erection during sexual activity, they are said to have sexual dysfunction. Long-term illnesses such as neurological conditions, insufficient hormones, heart conditions, diabetes, and adverse drug reactions are the main causes. In addition, it may arise as a result of inadequate blood flow to the penis, obesity, excessive alcohol consumption, smoking, and psychological issues. A comprehensive range of interventions, including penile implants, medication, erection aids, and lifestyle modifications such as quitting smoking, increasing physical activity, consuming less alcohol, and injecting drugs into the penis, can be used to treat erectile dysfunction. Throughout the forecast period, rising public awareness of erectile dysfunction or illnesses is expected to drive growth in the global market. Detailed analysis of the erectile dysfunction market emphasizes various market factors, including opportunities, constraints, trends, and drivers. The competitive landscape highlights significant players in the erectile dysfunction space and their primary expansion plans.